查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1612568

生技藥品安全測試市場：按產品類型、應用和最終用戶分類 - 2025-2030 年全球預測

Biologics Safety Testing Market by Product (Consumable, Instruments, Services), Test Type (Bioburden Tests, Endotoxin Tests, Mycoplasma Tests), Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年生技藥品安全測試市場價值為56.2億美元，預計到2024年將達到64.3億美元，複合年成長率為14.71%，預計到2030年將達到147億美元。

調查方法包括用於確保生物製藥安全的程序和技術，例如疫苗、血液製品和其他生物技術衍生的療法。這些測試對於保護公眾健康至關重要，可確保產品在獲得核准或分銷之前不含細菌、病毒和其他污染物。生技藥品安全測試應用跨越多個階段，包括細胞庫表徵、原料測試、製程雜質分析和最終產品測試，主要服務於製藥和生物技術產業。市場成長的主要驅動力是對生物製藥的需求不斷成長以及要求嚴格安全測試的法律規範。快速檢測測試的開發和測試流程自動化等技術進步提供了巨大的潛在機會。公司應專注於增強現有技術並與其他生物技術公司合作，以擴大測試能力並滿足不斷變化的監管要求。生物相似藥和個人化醫療的擴張也凸顯了潛在的成長潛力。然而，由於先進測試方法的高成本和對專業人員的需求而受到限制，阻礙了成長，特別是對於中小型企業而言。區域監管差異進一步加劇了全球測試標準化的複雜性，並給國際市場參與者帶來了挑戰。創新的核心應該是具有成本效益的、快速的多參數測試，以簡化流程並縮短上市時間。專注於整合新型診​​斷工具、生物感測器和人工智慧進行預測分析的研究投資可以改善安全結果並增強市場佔有率。市場動態是動態且受到嚴格的監管，需要適應性策略來應對其複雜性。持續評估監管變化、技術創新和市場需求對於保持競爭力和推動這一重要產業的成長至關重要。

主要市場統計
基準年[2023] 56.2億美元
預計年份 [2024] 64.3億美元
預測年份 [2030] 147億美元
複合年成長率（%） 14.71%

市場動態：揭示快速發展的生技藥品安全測試市場的關鍵市場洞察

供需的動態交互作用正在改變生技藥品安全測試市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 臨床試驗中安全監測和測試需求快速增加
    • 藥物召回、政府措施和生技藥品安全標準的增加
    • 醫療設備生產、貿易和品質評價的增加
  • 市場限制因素
    • 藥物開發中安全測試的高成本
  • 市場機會
    • 生物製藥安全檢測的創新與進步
    • 擴大重組蛋白和細胞/基因治療的研究以提高安全性
  • 市場挑戰
    • 缺乏熟練的專業人員進行精確的測試

波特五力：駕馭生技藥品安全測試市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解生技藥品安全測試市場的外部影響

外部宏觀環境因素在塑造生技藥品安全測試市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解生技藥品安全偵測市場的競爭格局

生技藥品安全測試市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣生技藥品安全測試市場供應商績效評估

FPNV定位矩陣是評估生技藥品安全測試市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，規劃生技藥品安全測試市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對生技藥品安全測試市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 臨床試驗活動中安全監測和測試的需求迅速增加
      • 越來越多的藥物召回以及政府有關生物製藥安全的舉措和標準
      • 增加醫療設備的生產和貿易以及品質評估
    • 抑制因素
      • 藥物研發安全性測試高成本
    • 機會
      • 生物安全檢測的創新與進步
      • 擴大重組蛋白和細胞/基因治療的研究以提高安全性
    • 任務
      • 缺乏能夠進行準確測試的熟練專業人員
  • 市場區隔分析
    • 產品：服務對於幫助生物製藥公司應對複雜的法規環境的重要性
    • 用途：擴大採用疫苗和治療藥物開發，以檢驗疫苗和新療法的功效和安全性
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章生技藥品安全檢測市場：分產品

  • 消耗品
  • 裝置
  • 服務

第7章按測試類型分類的生技藥品安全測試市場

  • 微生物附著量測試
  • 內毒素檢查
  • 黴漿菌檢測
  • 殘留宿主細胞蛋白質和DNA檢測測試
  • 無菌測試
  • 病毒安全測試

第8章生技藥品安全測試市場：依應用分類

  • 血液及血液相關製品的開發
  • 細胞/基因治療產品的開發
  • 單株抗體的開發
  • 疫苗和治療藥物開發

第9章生技藥品安全測試市場：依最終用戶分類

  • 學術研究所
  • 合約研究組織/契約製造組織
  • 製藥和生物技術公司

第10章美洲生技藥品安全檢測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太生技藥品安全檢測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東、非洲生技藥品安全檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Oxford Nanopore Technologies 和 PasoQuest 合作進行突破性的生物製藥安全測試
    • 擴大生物製藥生產：梯瓦烏爾姆工廠的戰略展望與未來計劃
    • 清潔細胞擴張提高了歐洲的生物製藥測試能力
  • 戰略分析和建議

公司名單

  • Accugen Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Almac Group Limited
  • Associates of Cape Cod, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • BSL Bioservice Scientific Laboratories Munich GmbH
  • Charles River Laboratories International, Inc.
  • Creative Biolabs, Inc.
  • Eagle Analytical Services
  • Eurofins Scientific Limited
  • F. Hoffmann-La Roche Ltd.
  • FUJIFILM Wako Pure Chemical Corporation
  • Laboratory Corporation of America Holdings
  • Lonza Group AG
  • Maravai Lifesciences
  • Merck KGaA
  • Microcoat Biotechnologie GmbH
  • Nelson Laboratories, LLC by Sterigenics International LLC
  • Pacific BioLabs by Northview Biosciences, Inc.
  • Promega Corporation
  • PromoCell GmbH
  • QIAGEN GmbH
  • Rockland Immunochemicals, Inc.
  • Samsung Biologics
  • Sartorius AG
  • SGS SA
  • SGS Societe Generale de Surveillance SA
  • Thermo Fisher Scientific, Inc.
Product Code: MRR-437D4595795B

The Biologics Safety Testing Market was valued at USD 5.62 billion in 2023, expected to reach USD 6.43 billion in 2024, and is projected to grow at a CAGR of 14.71%, to USD 14.70 billion by 2030.

Biologics safety testing encompasses the procedures and methodologies utilized to ensure the safety of biological products, which include vaccines, blood products, and other biotechnology-derived therapeutics. Essential for safeguarding public health, these tests are imperative to confirm the absence of bacterial, viral, and other contaminants before product approval and distribution. The application of biologics safety testing spans across multiple stages, including cell bank characterization, raw materials testing, process impurities analysis, and final product testing, primarily serving the pharmaceutical and biotechnology industries. Market growth is largely driven by the escalating demand for biopharmaceuticals, coupled with stringent regulatory frameworks mandating rigorous safety studies. Technological advancements, such as the development of rapid detection tests and automation in testing processes, offer substantial potential opportunities. Businesses should focus on enhancing existing technologies and collaborating with other biotech firms to broaden their testing capabilities and meet evolving regulatory requirements. The expansion of biosimilars and personalized medicine also highlights potential growth avenues. However, the market faces limitations due to high costs associated with sophisticated testing methodologies and the requirement for expert personnel, impeding growth, especially in smaller companies. Regulatory differences across regions further complicate global test standardization, posing challenges for international market players. Innovation should center around cost-effective, rapid, and multi-parameter tests to streamline processes and reduce time-to-market. Investment in research focusing on novel diagnostic tools, biosensors, and integrating AI for predictive analysis can enhance safety outcomes, thus fortifying market presence. Given its dynamic and highly regulated nature, the biologics safety testing market necessitates adaptive strategies to navigate its complexities. Continual assessment of regulatory changes, technical innovation, and market demands is crucial to maintaining competitiveness and fostering growth in this vital sector.

KEY MARKET STATISTICS
Base Year [2023] USD 5.62 billion
Estimated Year [2024] USD 6.43 billion
Forecast Year [2030] USD 14.70 billion
CAGR (%) 14.71%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biologics Safety Testing Market

The Biologics Safety Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Exponential need for safety monitoring & testing in clinical trials activities
    • Growing number of drug recalls and government initiatives and standards for biologics product safety
    • Increasing production and trade of medical devices and their quality evaluation
  • Market Restraints
    • High-cost requirement of safety testing for the development of drugs
  • Market Opportunities
    • Technological innovation and advancements in biologic safety testing
    • Expanding research for improved safety recombinant protein and cell & gene therapy
  • Market Challenges
    • Lack of skilled professionals to perform accurate testing

Porter's Five Forces: A Strategic Tool for Navigating the Biologics Safety Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biologics Safety Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biologics Safety Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biologics Safety Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biologics Safety Testing Market

A detailed market share analysis in the Biologics Safety Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biologics Safety Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biologics Safety Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biologics Safety Testing Market

A strategic analysis of the Biologics Safety Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biologics Safety Testing Market, highlighting leading vendors and their innovative profiles. These include Accugen Laboratories, Inc., Agilent Technologies, Inc., Almac Group Limited, Associates of Cape Cod, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, BSL Bioservice Scientific Laboratories Munich GmbH, Charles River Laboratories International, Inc., Creative Biolabs, Inc., Eagle Analytical Services, Eurofins Scientific Limited, F. Hoffmann-La Roche Ltd., FUJIFILM Wako Pure Chemical Corporation, Laboratory Corporation of America Holdings, Lonza Group AG, Maravai Lifesciences, Merck KGaA, Microcoat Biotechnologie GmbH, Nelson Laboratories, LLC by Sterigenics International LLC, Pacific BioLabs by Northview Biosciences, Inc., Promega Corporation, PromoCell GmbH, QIAGEN GmbH, Rockland Immunochemicals, Inc., Samsung Biologics, Sartorius AG, SGS S.A., SGS Societe Generale de Surveillance SA, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Biologics Safety Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Consumable, Instruments, and Services.
  • Based on Test Type, market is studied across Bioburden Tests, Endotoxin Tests, Mycoplasma Tests, Residual Host-Cell Proteins & DNA Detection Tests, Sterility Tests, and Virus Safety Tests.
  • Based on Application, market is studied across Blood & Blood-Related Products Development, Cellular & Gene Therapy Products Development, Monoclonal Antibodies Development, and Vaccine & Therapeutics Development.
  • Based on End-User, market is studied across Academic & Research Institutes, Contract Research Organization/ Contract Manufacturing Organization, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Exponential need for safety monitoring & testing in clinical trials activities
      • 5.1.1.2. Growing number of drug recalls and government initiatives and standards for biologics product safety
      • 5.1.1.3. Increasing production and trade of medical devices and their quality evaluation
    • 5.1.2. Restraints
      • 5.1.2.1. High-cost requirement of safety testing for the development of drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological innovation and advancements in biologic safety testing
      • 5.1.3.2. Expanding research for improved safety recombinant protein and cell & gene therapy
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of skilled professionals to perform accurate testing
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Cruciality of services for biopharmaceutical companies to navigate the complex regulatory landscapes
    • 5.2.2. Application: Increasing adoption in vaccine & therapeutics development to validate the effectiveness and safety of vaccines and new therapeutic drugs
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biologics Safety Testing Market, by Product

  • 6.1. Introduction
  • 6.2. Consumable
  • 6.3. Instruments
  • 6.4. Services

7. Biologics Safety Testing Market, by Test Type

  • 7.1. Introduction
  • 7.2. Bioburden Tests
  • 7.3. Endotoxin Tests
  • 7.4. Mycoplasma Tests
  • 7.5. Residual Host-Cell Proteins & DNA Detection Tests
  • 7.6. Sterility Tests
  • 7.7. Virus Safety Tests

8. Biologics Safety Testing Market, by Application

  • 8.1. Introduction
  • 8.2. Blood & Blood-Related Products Development
  • 8.3. Cellular & Gene Therapy Products Development
  • 8.4. Monoclonal Antibodies Development
  • 8.5. Vaccine & Therapeutics Development

9. Biologics Safety Testing Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Contract Research Organization/ Contract Manufacturing Organization
  • 9.4. Pharmaceutical & Biotechnology Companies

10. Americas Biologics Safety Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Biologics Safety Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Biologics Safety Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Oxford Nanopore Technologies and PathoQuest Collaborate on Groundbreaking Biopharmaceutical Safety Test
    • 13.3.2. Expanding Biologics Production: A Strategic Look at Teva's Ulm Facility and Future Plans
    • 13.3.3. Expansion of Clean Cells Advances Biopharmaceutical Testing Capabilities in Europe
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Accugen Laboratories, Inc.
  • 2. Agilent Technologies, Inc.
  • 3. Almac Group Limited
  • 4. Associates of Cape Cod, Inc.
  • 5. Becton, Dickinson and Company
  • 6. Bio-Rad Laboratories, Inc.
  • 7. bioMerieux SA
  • 8. BSL Bioservice Scientific Laboratories Munich GmbH
  • 9. Charles River Laboratories International, Inc.
  • 10. Creative Biolabs, Inc.
  • 11. Eagle Analytical Services
  • 12. Eurofins Scientific Limited
  • 13. F. Hoffmann-La Roche Ltd.
  • 14. FUJIFILM Wako Pure Chemical Corporation
  • 15. Laboratory Corporation of America Holdings
  • 16. Lonza Group AG
  • 17. Maravai Lifesciences
  • 18. Merck KGaA
  • 19. Microcoat Biotechnologie GmbH
  • 20. Nelson Laboratories, LLC by Sterigenics International LLC
  • 21. Pacific BioLabs by Northview Biosciences, Inc.
  • 22. Promega Corporation
  • 23. PromoCell GmbH
  • 24. QIAGEN GmbH
  • 25. Rockland Immunochemicals, Inc.
  • 26. Samsung Biologics
  • 27. Sartorius AG
  • 28. SGS S.A.
  • 29. SGS Societe Generale de Surveillance SA
  • 30. Thermo Fisher Scientific, Inc.

LIST OF FIGURES

  • FIGURE 1. BIOLOGICS SAFETY TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. BIOLOGICS SAFETY TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. BIOLOGICS SAFETY TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. BIOLOGICS SAFETY TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOLOGICS SAFETY TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOLOGICS SAFETY TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY CONSUMABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY BIOBURDEN TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY ENDOTOXIN TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY MYCOPLASMA TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY RESIDUAL HOST-CELL PROTEINS & DNA DETECTION TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY STERILITY TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY VIRUS SAFETY TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY BLOOD & BLOOD-RELATED PRODUCTS DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY CELLULAR & GENE THERAPY PRODUCTS DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY MONOCLONAL ANTIBODIES DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY VACCINE & THERAPEUTICS DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION/ CONTRACT MANUFACTURING ORGANIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. BIOLOGICS SAFETY TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 196. BIOLOGICS SAFETY TESTING MARKET, FPNV POSITIONING MATRIX, 2023